GLECAPREVIR-PIBRENTASVIR (Maviret®)
Clinical Indication
Hepatitis C
Comments
In line with NICE TA 499
Date of classification
March 2018
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.